196 related articles for article (PubMed ID: 32553721)
21. Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
Padoan A; Zuin S; Cosma C; Basso D; Plebani M; Bonfante F
Clin Chim Acta; 2020 Nov; 510():654-655. PubMed ID: 32818490
[No Abstract] [Full Text] [Related]
22. Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay.
Tang NY; Yeo KJ; van Wijk XMR
Clin Chim Acta; 2020 Oct; 509():293-294. PubMed ID: 32598879
[No Abstract] [Full Text] [Related]
23. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
[No Abstract] [Full Text] [Related]
24. Clinical chemistry tests for patients with COVID-19 - important caveats for interpretation.
Kavsak PA; de Wit K; Worster A
Clin Chem Lab Med; 2020 Jun; 58(7):1142-1143. PubMed ID: 32301748
[No Abstract] [Full Text] [Related]
25. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
26. What to Expect from Antibody Assays of SARS-CoV-2?
Yi X; Cao J
J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
[No Abstract] [Full Text] [Related]
27. The Promise and Peril of Antibody Testing for COVID-19.
Abbasi J
JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
[No Abstract] [Full Text] [Related]
28. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.
Gemcioglu E; Erden A; Davutoglu M; Karabuga B; Kucuksahin O
J Clin Rheumatol; 2020 Sep; 26(6):236-237. PubMed ID: 32694351
[No Abstract] [Full Text] [Related]
29. Non-Specific Laboratory Tests in Patients with COVID-19.
Borai A
Ann Clin Lab Sci; 2020 Jul; 50(4):528-535. PubMed ID: 32826251
[TBL] [Abstract][Full Text] [Related]
30. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients.
Khartabil TA; Russcher H; van der Ven A; de Rijke YB
Crit Rev Clin Lab Sci; 2020 Sep; 57(6):415-431. PubMed ID: 32568604
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
[TBL] [Abstract][Full Text] [Related]
32. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
Lippi G; Plebani M
Clin Chim Acta; 2020 Jun; 505():190-191. PubMed ID: 32145275
[No Abstract] [Full Text] [Related]
33. Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Gatto M; Perricone C; Tonello M; Bistoni O; Cattelan AM; Bursi R; Cafaro G; De Robertis E; Mencacci A; Bozza S; Vianello A; Iaccarino L; Gerli R; Doria A; Bartoloni E
Clin Exp Rheumatol; 2020; 38(4):754-759. PubMed ID: 32723434
[TBL] [Abstract][Full Text] [Related]
34. Computed tomography (CT) scan challenges the result of SARS-CoV-2 nucleic acid test in a suspected COVID-19 case.
Yan K; Zhang J; Zhang Y; Zhang S; Cai T; Zheng J
Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1362-1363. PubMed ID: 32319876
[No Abstract] [Full Text] [Related]
35. An Uncomplicated Delivery in a Patient with Covid-19 in the United States.
Iqbal SN; Overcash R; Mokhtari N; Saeed H; Gold S; Auguste T; Mirza MU; Ruiz ME; Chahine JJ; Waga M; Wortmann G
N Engl J Med; 2020 Apr; 382(16):e34. PubMed ID: 32237670
[No Abstract] [Full Text] [Related]
36. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report.
Kauv J; Lê MP; Veyrier M; Le Hingrat Q; Visseaux B; Massias L; Chauveheid MP; Descamps D; Ghosn J; Peytavin G
J Antimicrob Chemother; 2020 Sep; 75(9):2706-2707. PubMed ID: 32457980
[No Abstract] [Full Text] [Related]
37. The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis.
Aziz M; Fatima R; Lee-Smith W; Assaly R
Crit Care; 2020 May; 24(1):255. PubMed ID: 32456658
[No Abstract] [Full Text] [Related]
38. Mild versus severe COVID-19: Laboratory markers.
Velavan TP; Meyer CG
Int J Infect Dis; 2020 Jun; 95():304-307. PubMed ID: 32344011
[TBL] [Abstract][Full Text] [Related]
39. Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19).
Gutiérrez López de Ocáriz X; Castro Quismondo N; Vera Guerrero E; Rodríguez Rodríguez M; Ayala Díaz R; Martínez López J
Int J Lab Hematol; 2020 Dec; 42(6):e280-e282. PubMed ID: 32851784
[No Abstract] [Full Text] [Related]
40. Preterm birth: Potential risk factor for greater COVID-19 severity?
Debevec T; Burtscher J; Millet GP
Respir Physiol Neurobiol; 2020 Sep; 280():103484. PubMed ID: 32599161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
